Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06434948 · ClinicalTrials.gov registry record · Phase 2
The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery
A Phase 2 study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT06434948: Clinical Trial Phase 2 study, sponsored by University of Missouri-Columbia.
NCT06434948 is a Phase 2 study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06434948, a Phase 2 study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether giving omega-3 fatty acids prior to and after cardiac bypass surgeries decreases the incidence of postoperative delirium in patients aged 65 and over.
Primary Outcome
Number of patients that experienced postoperative delirium during the study.
Interventions
- DRUG Omega-3 Ethyl Esters 4 g
- DRUG Omega-3 Ethyl Esters 2 g
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2026-03-03 |
| Est. Completion | 2026-04-29 |
| Phase | Phase 2 |
Why NCT06434948 stopped before completion
NCT06434948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Omega-3 Ethyl Esters 4 g is the first listed.
NCT06434948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06434948 about?
NCT06434948 is a clinical study titled "The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery". The purpose of this study is to determine whether giving omega-3 fatty acids prior to and after cardiac bypass surgeries decreases the incidence of postoperative delirium in patients aged 65 and over.
What is the current status of trial NCT06434948?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2026-03-03. Estimated completion is 2026-04-29.
What interventions are being tested in trial NCT06434948?
The interventions under investigation include: Omega-3 Ethyl Esters 4 g (DRUG), Omega-3 Ethyl Esters 2 g (DRUG).
Who is sponsoring clinical trial NCT06434948?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06434948's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI